Active Supportive Care and Symptom Management Grants
| PI Name | Organization - Company | Title |
FOA |
|---|---|---|---|
| Rogers, Laura Q | University Of Alabama At Birmingham | Role of gut microbe composition in psychosocial symptom response to exercise training in breast cancer survivors | PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program |
| Perkins, Susan M | Indiana Univ-Purdue Univ At Indianapolis | Evaluation of the Communication Plan Early through End-of-Life (COMPLETE) Intervention | PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program |
| Hui, David | University Of Tx Md Anderson Can Ctr | Strategies for Persistent Agitated Delirium in Palliative Care | PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program |
| Mao, Jun J | Sloan-Kettering Inst Can Research | Effect and Mechanism of Acupuncture for Cancer-related Cognitive Impairment (ENHANCE) | PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program |
| Washington, Karla | Washington University | Problem-Solving Therapy for Cancer Caregivers: A Randomized Clinical Trial in Outpatient Palliative Care | PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program |
| Hui, David | University Of Tx Md Anderson Can Ctr | Efficacy and Safety of Rapid-Onset Opioids for Exertional Dyspnea in Cancer Patients | PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program |
| Bylund, Carma L. | University Of Florida | Dignity Therapy for Older Cancer Patients: Identifying Mechanisms and Moderators | PAR-18-869: Modular R01s in Cancer Control and Population Sciences |
| Salvemini, Daniela | Saint Louis University | Fingolimod and Ozanimod for the treatment and prevention of chemobrain | PAR-19-325: Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies |
| Hanks, Brent Allen | Duke University | Role of the tumor NLRP3 inflammasome in the generation of anti-PD-1 antibody immunotherapy-associated toxicities | PAR-19-325: Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies |
| Geisler, Stefanie | Washington University | Developing mechanism-based strategies to treat chemotherapy-induced peripheral neuropathy | PAR-19-325: Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies |
| Stover, Daniel G. | Ohio State University | Video Intervention to Address Pre-Test Patient Education for Tumor Genomic Testing | PAR-19-356: NCI Clinical and Translational Exploratory/Developmental Studies |
| Krause, Diane S | Yale University | "Exploration of Human Parathyroid Cellular Organization and Function" | PAR-19-356: NCI Clinical and Translational Exploratory/Developmental Studies |
| Strati, Paolo | University Of Tx Md Anderson Can Ctr | Targeting Myeloid Cells to Mitigate Immune Effector Cell-Associated Neurotoxicity Syndrome in Large B-cell Lymphoma | PAR-19-356: NCI Clinical and Translational Exploratory/Developmental Studies |
| Robien, Kimberly Z | George Washington University | Body composition and chemotherapy toxicity among women being treated for breast cancer | PAR-19-356: NCI Clinical and Translational Exploratory/Developmental Studies |
| Ibrahim, Mohab M | University Of Arizona | Repurposing Sulfasalazine in a Two-Arm Phase Two Double-Blind Randomized Clinical Trial for the Adjunct Management of Breast Cancer-Induced Bone Pain | PAR-19-356: NCI Clinical and Translational Exploratory/Developmental Studies |